Hakwon Kim
Yongin, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Two Novel 1,4-Naphthoquinone Derivatives as Potent Agents Against Multidrug-Resistant Staphylococcus aureus and Pathogenic Gram-Positive Bacteria.
Journal: Drug development research
Published: April 28, 2026
Potent Bacteriostatic Activity of a Naphthalene-2-Acyl Imidazolium Salt against Xanthomonas oryzae pv. oryzae.
Journal: The plant pathology journal
Published: November 25, 2025
Preclinical Pharmacological and Toxicological Evaluation of SB5794, a Novel Aryl Hydrocarbon Receptor Modulator on the Kynurenine-AhR Axis.
Journal: Biomolecules & therapeutics
Published: November 11, 2025
Synthesis and Anti-Inflammatory Activity of N(2)-Arylindazol-3(2H)-One Derivatives: Copper-Promoted Direct N-Arylation via Chan-Evans-Lam Coupling.
Journal: Molecules (Basel, Switzerland)
Published: August 29, 2023
Identification of a Novel ERK5 (MAPK7) Inhibitor, MHJ-627, and Verification of Its Potent Anticancer Efficacy in Cervical Cancer HeLa Cells.
Journal: Current issues in molecular biology
Published: June 29, 2023
Synthesis of 1,4-Dialkoxynaphthalene-Based Imidazolium Salts and Their Cytotoxicity in Cancer Cell Lines.
Journal: International journal of molecular sciences
Published: December 30, 2022
Scalable Synthesis of TRPV1 Antagonist Bipyridinyl Benzimidazole Derivative via the Suzuki-Miyaura Reaction and Selective SeO2 Oxidation.
Journal: Molecules (Basel, Switzerland)
Published: November 13, 2022
Identification of a potent NAFLD drug candidate for controlling T2DM-mediated inflammation and secondary damage in vitro and in vivo.
Journal: Frontiers in pharmacology
Published: May 14, 2022
Last Updated: 09/26/2026